Segment 17: Managing Depression: Use of Counseling to Improve Outcomes
Mar 26, 2015 |
Ray Tancredi, RPh, MBA, CSP, vice president of specialty pharmacy development at Walgreens; Cheryl Allen, BS Pharm, MBA, vice president of business development and industry relations for Diplomat Pharmacy; Nicholas Karalis, RPh, of Elwyn Pharmacy Group; Stacey Ness, PharmD, RPh, CSP, MSCS, AAHIVP, director of specialty clinical services for Managed Healthcare Associates*; and Renee Rayburg, RPh, senior director of clinical consulting at Artemetrx, discuss the effective management of depression during the treatment of hepatitis C patients.
Karalis said there are standard protocols for questions patients, but noted that when a patient indicates they have depression, the prescriber provides available options that typically come back to oral high cost dual agents. Ness emphasized the importance of depression screening in any chronic condition because of the associated risk of non-adherence to therapy.
With the flood of highly effective treatments hitting the market, Allen said that real world outcomes in terms of a sustained virological response would be the determining factor in the use of these drugs. Rayburg agreed, adding that any treatment program should include patient follow-up and medication reminders to ensure a high cure rate.
*The views expressed are those of the individual alone and not of Managed Health Care Associates, Inc.
Episode #1
Episode 1: What is Specialty Pharmacy?
Episode #2
Episode 2: Understanding and Exploring the Practice of Specialty Pharmacy: How is quality measured?
Episode #3
Episode 3: How Do Prior Authorization and Cost Impact Patient Care?
Episode #4
Episode 4 - Navigating Barriers to Therapy and Reimbursement
Episode #5
Episode 6: Evaluating Specialty Pharmacy: Reliable Methods to Measure Quality
Episode #6
Episode 5: Is There Value to Specialty Pharmacy Accreditation?
Episode #7
Episode 7: Data Aggregation in Specialty Pharmacy
Episode #8
Episode 8: New Products and Limited Distribution Channels
Episode #9
Episode 9: Role of Biosimilars in the Specialty Marketplace
Episode #10
Episode 10: How Do We Know Specialty Pharmacies Are Providing Good Customer Service?
Episode #11
Episode 11: Management of High Cost Medications
Episode #12
Episode 12: Value of Specialty Pharmacy in Oncology
Episode #13
Episode 13: Challenges of Medication Adherence in the Oncology Population
Episode #14
Episode 14: Strategies to Mitigate Side Effects and Management of Comorbidities
Episode #15
Episode 15: Are High Cost Hepatitis C Medications Worth the Price Tag?
Episode #16
Episode 16: Encouraging Medication Adherence in Hepatitis C
Episode #17
Segment 17: Managing Depression: Use of Counseling to Improve Outcomes
Episode #18
Segment 18: Hepatitis C Virus: Achieving an SVR and Unmet Patient Needs